| NCT07003919 | Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) | RECRUITING | PHASE3 | 2025-06-24 | 2028-05 | 2026-11 |
| NCT05741476 | Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-02-21 | 2029-10 | 2025-11 |
| NCT04492683 | Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children | UNKNOWN | PHASE2 | 2020-08-28 | 2024-03 | 2024-03 |
| NCT03859700 | Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children | COMPLETED | PHASE3 | 2018-12-06 | 2025-05-13 | 2025-05-13 |
| NCT03352726 | A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects | COMPLETED | PHASE1 | 2017-11-24 | 2018-06-29 | 2018-06-29 |
| NCT03211247 | Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age | COMPLETED | PHASE3 | 2017-07-31 | 2022-04-27 | 2019-08-20 |
| NCT03013517 | Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children | UNKNOWN | PHASE3 | 2017-01-23 | 2023-03 | 2019-11-23 |
| NCT02916446 | Safety Study of Viaskin Peanut to Treat Peanut Allergy | COMPLETED | PHASE3 | 2016-10 | 2020-10-07 | 2017-09-22 |
| NCT03035370 | Viaskin Pertussis Vaccine Trial | COMPLETED | PHASE1 | 2016-09-05 | 2018-04-25 | 2018-04-25 |
| NCT02636699 | Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy | COMPLETED | PHASE3 | 2015-12 | 2017-08-18 | 2017-08-18 |
| NCT02223182 | Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy | COMPLETED | PHASE1, PHASE2 | 2014-11 | 2020-12-22 | 2017-12-14 |
| NCT01955109 | Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children | COMPLETED | PHASE2 | 2013-09 | 2016-09 | 2016-09 |
| NCT01675882 | Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy | COMPLETED | PHASE2 | 2012-08 | 2014-07 | 2014-07 |
| NCT01170286 | Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy | COMPLETED | PHASE1 | 2010-07 | 2012-02 | 2012-02 |